Polymer development company Covestro has developed a new type of polycarbonate, Makrolon Rx2235, which is highly fluid and suitable for use in healthcare applications, including personal devices and surgical applications.
In the medical industry, the trend of miniaturization is affecting product design. Smaller medical devices, such as in vivo drug delivery or monitoring applications, require a seamless, unobtrusive, and lightweight design to improve patient comfort and overall compliance. In addition, smaller devices are often used during surgery to extend patient recovery time.
"Makrolon Rx2235 polycarbonate sets a new benchmark for flow length, bringing the expected transparency and toughness of polycarbonate to help manufacturers fill it," said Pierre Moulinié, Covestro's polycarbonate division and global head of medical technology. Very thin walls and accurately replicate complex features with lower pressure. "
According to ISO 10993-1 test requirements, polycarbonates are biocompatible and designed to be sterilized using gamma or electron beam methods. It complements Makrolon 2258 polycarbonate, another ideal medical device material. This grade is suitable for ETO and steam sterilization, meets many ISO 10993-1 test requirements, and is biocompatible.
"Makrolon Rx2235 polycarbonate is an important complement to our broad range of medical polycarbonate products. This is just how we continue to innovate and expand our polycarbonate portfolio The latest example of the new technology enables medical OEMs to get the advanced materials needed to design, develop and produce the next breakthrough.